JP2011518125A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518125A5 JP2011518125A5 JP2011501904A JP2011501904A JP2011518125A5 JP 2011518125 A5 JP2011518125 A5 JP 2011518125A5 JP 2011501904 A JP2011501904 A JP 2011501904A JP 2011501904 A JP2011501904 A JP 2011501904A JP 2011518125 A5 JP2011518125 A5 JP 2011518125A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fab fragment
- heavy chain
- light chain
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 38
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 38
- 102000051325 Glucagon Human genes 0.000 claims 2
- 108060003199 Glucagon Proteins 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 2
- 229960004666 glucagon Drugs 0.000 claims 2
- 102220479740 Cell division cycle protein 123 homolog_S11I_mutation Human genes 0.000 claims 1
- 102220502941 Geranylgeranyl transferase type-2 subunit alpha_D10E_mutation Human genes 0.000 claims 1
- 102220502946 Geranylgeranyl transferase type-2 subunit alpha_D10N_mutation Human genes 0.000 claims 1
- 108010063919 Glucagon Receptors Proteins 0.000 claims 1
- 102100040890 Glucagon receptor Human genes 0.000 claims 1
- 101001040075 Homo sapiens Glucagon receptor Proteins 0.000 claims 1
- 101001040082 Mus musculus Glucagon receptor Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 101001040081 Rattus norvegicus Glucagon receptor Proteins 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 102220083031 rs746990000 Human genes 0.000 claims 1
- 102220322685 rs777811020 Human genes 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3990708P | 2008-03-27 | 2008-03-27 | |
| US61/039,907 | 2008-03-27 | ||
| PCT/US2009/037349 WO2009120530A1 (en) | 2008-03-27 | 2009-03-17 | Glucagon receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518125A JP2011518125A (ja) | 2011-06-23 |
| JP2011518125A5 true JP2011518125A5 (enExample) | 2012-04-12 |
| JP5438095B2 JP5438095B2 (ja) | 2014-03-12 |
Family
ID=40794248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011501904A Expired - Fee Related JP5438095B2 (ja) | 2008-03-27 | 2009-03-17 | グルカゴン受容体アンタゴニスト |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7968686B2 (enExample) |
| EP (1) | EP2268670A1 (enExample) |
| JP (1) | JP5438095B2 (enExample) |
| KR (1) | KR101235934B1 (enExample) |
| CN (1) | CN101983208A (enExample) |
| AR (1) | AR070844A1 (enExample) |
| AU (1) | AU2009228866A1 (enExample) |
| BR (1) | BRPI0910118A2 (enExample) |
| CA (1) | CA2719761A1 (enExample) |
| CL (1) | CL2009000586A1 (enExample) |
| EA (1) | EA201071126A1 (enExample) |
| MX (1) | MX2010010517A (enExample) |
| PE (1) | PE20091674A1 (enExample) |
| TW (1) | TW201000126A (enExample) |
| WO (1) | WO2009120530A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102482350B (zh) * | 2009-09-08 | 2015-08-05 | 株式会社新药 | 作用于胰高血糖素受体的抗体及其应用 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| JO3756B1 (ar) | 2010-11-23 | 2021-01-31 | Regeneron Pharma | اجسام مضادة بشرية لمستقبلات الجلوكاجون |
| US8771696B2 (en) | 2010-11-23 | 2014-07-08 | Regeneron Pharmaceuticals, Inc. | Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor |
| DK2663579T3 (en) | 2011-01-14 | 2017-07-31 | Univ California | THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND PROCEDURES FOR USE THEREOF |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013059531A1 (en) * | 2011-10-20 | 2013-04-25 | Genentech, Inc. | Anti-gcgr antibodies and uses thereof |
| WO2013081993A1 (en) | 2011-12-02 | 2013-06-06 | Eli Lilly And Company | Anti-glucagon antibodies and uses thereof |
| SG11201508264UA (en) * | 2013-05-07 | 2015-11-27 | Rinat Neuroscience Corp | Anti-glucagon receptor antibodies and methods of use thereof |
| BR112016028726A2 (pt) * | 2014-06-08 | 2017-11-07 | Remd Biotherapeutics Inc | métodos de tratamento de um paciente diagnosticado com diabetes tipo 1, métodos de redução, supressão, atenuação ou inibição de um ou mais sintomas associados com t1d, e métodos de tratamento de um paciente que está em risco de t1d |
| KR102708864B1 (ko) | 2016-08-30 | 2024-09-25 | 리제너론 파마슈티칼스 인코포레이티드 | 글루카곤 수용체 신호전달을 간섭함에 의한 중증 인슐린 저항성의 치료 방법 |
| WO2018075792A1 (en) | 2016-10-20 | 2018-04-26 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
| UA129078C2 (uk) | 2017-01-27 | 2025-01-08 | Енджіем Байофармасьютикалз, Інк. | Білки, що зв'язують глюкагонові рецептори, та способи їх застосування |
| US12139546B2 (en) | 2017-08-22 | 2024-11-12 | Regeneron Pharmaceuticals, Inc. | Methods of treating urea cycle disorders by interfering with glucagon receptor signaling |
| CN110357959B (zh) | 2018-04-10 | 2023-02-28 | 鸿运华宁(杭州)生物医药有限公司 | Gcgr抗体及其与glp-1的融合蛋白质,以及其药物组合物和应用 |
| EP3829636A1 (en) | 2018-07-27 | 2021-06-09 | NGM Biopharmaceuticals, Inc. | Use of glucagon receptor antagonists with immunotherapeutic agent |
| WO2020125744A1 (zh) | 2018-12-21 | 2020-06-25 | 江苏恒瑞医药股份有限公司 | 双特异性蛋白 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776725A (en) | 1992-08-28 | 1998-07-07 | Zymogenetics, Inc. | Recombinant production of glucagon receptors |
| ATE285472T1 (de) | 1992-08-28 | 2005-01-15 | Novo Nordisk As | Glucagonrezeptoren |
| US6909031B2 (en) | 2000-12-06 | 2005-06-21 | Deltagen, Inc. | Transgenic mice containing glucagon receptor gene disruptions |
| AR036711A1 (es) | 2001-10-05 | 2004-09-29 | Bayer Corp | Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacologico |
| US7399853B2 (en) | 2003-04-28 | 2008-07-15 | Isis Pharmaceuticals | Modulation of glucagon receptor expression |
| WO2006005469A2 (en) | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with glucagon receptor (gcgr) |
| CN101484081A (zh) | 2006-07-04 | 2009-07-15 | 布拉科成像S.P.A.公司 | 生物组织尤其是肿瘤组织等的局部热切除装置 |
| CL2007002668A1 (es) * | 2006-09-20 | 2008-05-09 | Amgen Inc | Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2. |
-
2009
- 2009-03-12 PE PE2009000369A patent/PE20091674A1/es not_active Application Discontinuation
- 2009-03-12 CL CL2009000586A patent/CL2009000586A1/es unknown
- 2009-03-12 AR ARP090100889A patent/AR070844A1/es unknown
- 2009-03-13 TW TW098108296A patent/TW201000126A/zh unknown
- 2009-03-17 US US12/405,458 patent/US7968686B2/en not_active Expired - Fee Related
- 2009-03-17 WO PCT/US2009/037349 patent/WO2009120530A1/en not_active Ceased
- 2009-03-17 KR KR1020107021297A patent/KR101235934B1/ko not_active Expired - Fee Related
- 2009-03-17 JP JP2011501904A patent/JP5438095B2/ja not_active Expired - Fee Related
- 2009-03-17 MX MX2010010517A patent/MX2010010517A/es not_active Application Discontinuation
- 2009-03-17 BR BRPI0910118A patent/BRPI0910118A2/pt not_active IP Right Cessation
- 2009-03-17 CN CN2009801107130A patent/CN101983208A/zh active Pending
- 2009-03-17 EA EA201071126A patent/EA201071126A1/ru unknown
- 2009-03-17 AU AU2009228866A patent/AU2009228866A1/en not_active Abandoned
- 2009-03-17 CA CA2719761A patent/CA2719761A1/en not_active Abandoned
- 2009-03-17 EP EP09726006A patent/EP2268670A1/en not_active Withdrawn
-
2011
- 2011-05-16 US US13/108,073 patent/US20110212092A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011518125A5 (enExample) | ||
| JP2020079252A5 (enExample) | ||
| IL261585A (en) | Antigen-binding human proteins that bind beta-klotho, fgf receptors and their complexes | |
| JP2020500538A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| JP2022061992A5 (enExample) | ||
| IL259940B2 (en) | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists | |
| JP2011517447A5 (enExample) | ||
| RU2588467C3 (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| JP2019504032A5 (enExample) | ||
| JP2013538553A5 (enExample) | ||
| JP2018108081A5 (enExample) | ||
| JP2009225799A5 (enExample) | ||
| AR080698A1 (es) | Anticuerpo o fragmento del mismo que especificamente enlaza la variante de csf -1r humano, composicion farmaceutica que lo comprende, su uso para la manufactura de un medicamento util para el tratamiento de cancer y metodo para determinar si un sujeto es candidato para tratamiento de cancer basado e | |
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| JP2018521638A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2020517249A5 (enExample) | ||
| JP2012504634A5 (enExample) | ||
| JP2015522252A5 (enExample) | ||
| JP2010534478A5 (enExample) | ||
| JP2017514461A5 (enExample) | ||
| JP2010516229A5 (enExample) | ||
| JP2020508303A5 (enExample) | ||
| JP2012513214A5 (enExample) |